Zentera Therapeutics scoops up $20m Series A

Zentera Therapeutics, a Chinese biopharmaceutical company, has raised $20 million in Series A funding.

Zentera Therapeutics, a Chinese biopharmaceutical company, has raised $20 million in Series A funding. Tybourne Capital Management was the lead backer.

Source: Press Release